Strategic Wealth Partners’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding SBIO
ASN
CCP
NAM
CT
Strategic Wealth Partners's SBIO Position: Q4 2019 in Review
Strategic Wealth Partners sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q4 2019, closing a stake of 187 shares — an estimated $5 sold.
Strategic Wealth Partners first reported a position in SBIO in Q3 2019 and held it in 1 quarter. The position peaked at $5 in Q3 2019. 51 funds tracked by Wall St. Rank hold SBIO as of Q4 2019.
- Strategic Wealth Partners reported no remaining ALPS Medical Breakthroughs ETF position as of Q4 2019 after selling out during the quarter.
- Strategic Wealth Partners sold 187 ALPS Medical Breakthroughs ETF shares in Q4 2019, an estimated $5.
- Strategic Wealth Partners first reported a position in ALPS Medical Breakthroughs ETF in Q3 2019 and held it in 1 quarter.
- Strategic Wealth Partners's ALPS Medical Breakthroughs ETF position peaked at $5 in Q3 2019.
- 51 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q4 2019.
Based on Strategic Wealth Partners's 13F filing for Q4 2019, filed 30 Jan 2020.